Belgium s Galapagos to Build Gene Library for Pharmacia | GenomeWeb

NEW YORK, Nov. 14 – Belgian functional genomics company Galapagos Genomics said Wednesday that it had agreed to build a gene library for Pharmacia designed to help the pharmaceutical company to identify and validate drug targets for a range of diseases.

Galapagos has developed the PhenoSelect expression platform, which uses arrayed adenoviruses containing human genes to identify and validate targets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.